Genmab is a dual listed company with shares traded on the Copenhagen stock exchange in Denmark and on NASDAQ Global Select Market in the US.

Analyst Coverage

Analyst Coverage

Firm Analyst Contact Information
Bank of America/Merrill Lynch
Sachin Jain
Emily Field
Wimal Kapadia
Etzer Darout, PhD
Bryan, Garnier & Co
Dylan van Haaften
Carnegie Bank
Jesper Ilsøe
Peter Verdult
Yaron Werber, M.D.
Credit Suisse
Elizabeth Walton
Danske Markets Equities
Thomas Bowers
Deutsche Bank AG
Emmanuel Papadakis, PhD CFA
Rune Majlund Dahl
Goldman Sachs International
Keyur Parekh
Guggenheim Securities, LLC
Michael Schmidt, Ph.D.
Suzanna Queckbörner, PhD
H.C. Wainwright & Co.
Raghuram Selvaraju, Ph.D.
Jefferies International Ltd.
Peter Welford
J.P. Morgan
James Gordon
Jyske Bank
Henrik Hallengreen Laustsen
Kempen & Co
Suzanne van Voorthuizen
Morgan Stanley & Co. LLC
Matthew Harrison
Michael Novod
Michael Drøscher Jørgensen
RBC Capital Markets, LLC
Zoe Karamanoli
Societe Generale
Justin Smith
SVB Securities
Jonathan Chang
Søren Løntoft Hansen
Truist Securities
Asthika Goonewardene

Genmab A/S is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Genmab A/S's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Genmab A/S or its management. Genmab A/S does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

You are now leaving to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.